Landos Biopharma raises $10M in series A funding round — 3 insights

Landos Biopharma completed a series A financing round raising $10 million.

Here's what you should know:

1. Perceptive Advisors led the financing round, serving as the exclusive investor.

2. Landos is a pharmaceutical pipeline developing treatments for autoimmune diseases, specifically for Crohn's disease and ulcerative colitis.

3. The funding will be used to advance the development of BT-11, specifically to advance the product through its initial phase I clinical testing.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast